2022
DOI: 10.1038/s41598-022-07604-7
|View full text |Cite
|
Sign up to set email alerts
|

Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant

Abstract: In this retrospective, multicenter study, we determined the predictive value of imaging biomarkers in diabetic macular edema (DME) outcomes following dexamethasone (DEX) implant(s). Sixty-seven eyes of 47 patients’ best-corrected visual acuity (BCVA) and central foveal thickness (CFT) on optical coherence tomography (OCT) before and after intravitreal DEX implants were evaluated. Baseline imaging biomarkers were graded using fundus photography and OCT, and the predictive value of biomarkers for significant tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…After dexamethasone implants in eyes with DME, biomarkers such as subretinal fluid, inner segment/outer segment continuity, the lack of hyperreflective foci, and an attached vitreoretinal interface indicated improved visual results. Anti-VEGF (ranibizumab) biomarkers such as ellipsoid zone disruption and the lack of epiretinal membrane have been linked to superior therapy outcomes [13][14] . A potential predictive biomarker for the visual consequences of DME is the disorganization of the retinal inner layers.…”
Section: How To Detect Diabetic Macular Edemamentioning
confidence: 99%
“…After dexamethasone implants in eyes with DME, biomarkers such as subretinal fluid, inner segment/outer segment continuity, the lack of hyperreflective foci, and an attached vitreoretinal interface indicated improved visual results. Anti-VEGF (ranibizumab) biomarkers such as ellipsoid zone disruption and the lack of epiretinal membrane have been linked to superior therapy outcomes [13][14] . A potential predictive biomarker for the visual consequences of DME is the disorganization of the retinal inner layers.…”
Section: How To Detect Diabetic Macular Edemamentioning
confidence: 99%
“…[8][9][10][11] Several studies investigated OCT biomarkers in DME and found them to be predictive of treatment outcomes after intravitreal anti-VEGF injection and intravitreal steroid implant and to be related to the nal visual outcome. [12][13][14][15][16][17] In the last years, the high demand for screening and monitoring patients with DR prompted the development of Arti cial Intelligence (AI) in the ophthalmology eld in order to improve access of patients to DR screening and to improve diagnostic accuracy, particularly by means of retinal fundus images.…”
Section: Introductionmentioning
confidence: 99%
“…The clinician’s choice between these different drugs is usually based on several factors that consider the patient’s compliance and motivation, age, and some general and ophthalmological comorbidities [ 2 ]. Furthermore, several imaging biomarkers have been identified as particularly useful to guide the therapeutical option choice [ 3 ], but a univocal consensus has not yet been reached on this topic.…”
Section: Introductionmentioning
confidence: 99%
“…Optical coherence tomography (OCT) and OCT angiography (OCTA) allow non-invasive recognition of imaging features that define a “DME profile”, distinguishing an inflammatory DME pattern characterized by the presence of subretinal fluid (SRF) and a high number of hyper-reflective foci (HRF) [ 4 , 5 ]. Furthermore, numerous imaging (OCT and OCTA) biomarkers have been identified in DME eyes as predictive of treatment response or disease progression, such as the retinal thickening characteristics [ 3 , 6 , 7 ], the presence, position, and internal reflectivity of microaneurysms (MAS) [ 8 , 9 ], the vitreomacular interface abnormalities (VMIAs) [ 6 ], the ellipsoid zone/external limiting membrane (EZ/ELM) integrity/disruption [ 7 ], the presence of nonperfusion areas (NPAs) [ 10 , 11 ], the foveal avascular zone (FAZ) abnormalities in terms of circularity and dimension [ 12 ], the involvement of deep capillary complex (DCP) [ 10 , 13 ], and the suspended scattering particles in motion (SSPiM) [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%